This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.

Find out more here.

The HRA and the Science and Technology Committee inquiry on Research Integrity

Last updated on 6 Nov 2019

On 30 January 2018, our then Chair Professor Sir Jonathan Montgomery was invited to give evidence to the committee's inquiry on Research Integrity.

This page collates all of our content about the inquiry, including news items, blog posts and statements from the HRA.



Conflicts of Interest, a blog from Jonathan Montgomery (19 February 2018) - this includes written evidence submitted as a follow up to the Science and Technology committee

Research Waste, a blog from Juliet Tizzard (11 July 2018)

The HRA's statement in response to the Science and Technology committee's report on clinical trials transparency (29 October 2018)

The PACE trial. A letter in response to the committee's questions (6 February 2019)

The HRA's detailed response to recommendations in the Science and Technology committee's report on clinical trials transparency (22 February 2019)

The HRA's News story on the launch of the Make it Public consultation (17 June 2019)

Letter from Teresa Allen, Chief Executive of the Health Research Authority, to Sir Norman Lamb on contact with NHS sponsors regarding research transparency (22 August 2019)

Sir Norman Lamb's response to an open letter from TranspariMED and others (23 August 2019)

Letter from Sir Norman Lamb to the HRA on sanctions (9 September 2019)

Letter from Teresa Allen to Sir Norman Lamb on sanctions (7 October 2019)

On 29 October 2019, our Chair Professor Sir Terence Stephenson and our Director of Policy Juliet Tizzard gave follow-up evidence to the Committee. 



Follow up blog, Making it Public in Parliament by Juliet Tizzard (6 November 2019)

Back to our transparency agenda